New York State Common Retirement Fund’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,500
Closed -$570K 3624
2021
Q1
$570K Buy
9,500
+5,400
+132% +$195K ﹤0.01% 2389
2020
Q4
$61K Buy
+4,100
New +$57K ﹤0.01% 3163

New York State Common Retirement Fund's PAND Position: Q2 2021 in Review

New York State Common Retirement Fund sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 9,500 shares — an estimated $570K sold.

New York State Common Retirement Fund first reported a position in PAND in Q4 2020 and held it in 2 quarters. The position peaked at $570K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • New York State Common Retirement Fund reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,500 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $570K.
  • New York State Common Retirement Fund first reported a position in Pandion Therapeutics Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • New York State Common Retirement Fund's Pandion Therapeutics Inc. Common Stock position peaked at $570K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on New York State Common Retirement Fund's 13F filing for Q2 2021, filed 2 Aug 2021.